Cargando…
Cutaneous angiosarcoma treated with taxane‐based chemoradiotherapy: A multicenter study of 90 Japanese cases
Cutaneous angiosarcoma (CAS) is rare and most previous studies of CAS have been small case series, and randomized, phase II studies of CAS are limited. Since treatment options for CAS are controversial, and because only paclitaxel should be recommended based on high‐level evidence, it is important t...
Autores principales: | Fujimura, Taku, Furudate, Sadanori, Maekawa, Takeo, Kato, Hiroshi, Ito, Takamichi, Matsushita, Shigeto, Yoshino, Koji, Hashimoto, Akira, Muto, Yusuke, Ohuchi, Kentaro, Amagai, Ryo, Kambayashi, Yumi, Fujisawa, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892413/ https://www.ncbi.nlm.nih.gov/pubmed/36751323 http://dx.doi.org/10.1002/ski2.180 |
Ejemplares similares
-
Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases
por: MUTO, Yusuke, et al.
Publicado: (2022) -
Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163(+) Arginase 1(+) M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
por: Fujimura, Taku, et al.
Publicado: (2013) -
Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab
por: Amagai, Ryo, et al.
Publicado: (2023) -
Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis
por: Amagai, Ryo, et al.
Publicado: (2018) -
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate
por: Ishibashi, Masaya, et al.
Publicado: (2012)